XML 35 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
 6 Months Ended
Jul. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Compensation Costs
The compensation costs that have been charged against income were as follows (in thousands):

13-Weeks Ended26-Weeks Ended
July 31,
2021		August 1,
2020		July 31,
2021		August 1,
2020
Stock-based compensation expense by type:
Stock options
$— $— $174 $90 
Restricted stock units1,092 587 2,880 1,647 
Employee stock purchases
24 27 108 70 
Director deferred compensation15 23 21 47 
  Total stock-based compensation expense1,131 637 3,183 1,854 
Income tax benefit recognized279 168 758 423 
  Stock-based compensation expense, net of income tax$852 $469 $2,425 $1,431 
Schedule of Equity Awards Granted We have granted the following equity awards:
13-Weeks Ended26-Weeks Ended
July 31,
2021		August 1,
2020		July 31,
2021		August 1,
2020
Stock options
— — 4,384 27,000 
Restricted stock unit awards
790 3,264 62,031 337,749 
Performance-based restricted stock unit awards
— — 22,492 — 
Deferred stock units
174 1,120 258 3,263 
Schedule of Shares Purchased
The number of shares purchased, the average price per share, and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows:
13-Weeks Ended26-Weeks Ended
July 31,
2021		August 1,
2020		July 31,
2021		August 1,
2020
Shares purchased2,063 11,143 9,508 28,901 
Average price per share$58.56 $8.60 $43.44 $9.03 
Weighted-average fair value at grant date$11.39 $2.39 $11.44 $3.51